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D
espite the reduction in mortality with advances in treatment, comorbidity of renal dysfunction is still indicative of an extremely poor prognosis in patients with chronic heart failure (CHF). 1, 2 Therefore, evaluation of renal function for risk stratification of patients with CHF continues to be important.
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Renal tubule cells have diverse regulatory and endocrine functions. Renal tubule cells play a pivotal role in modulating acid base balance, active vitamin D synthesis, and reabsorption of sodium, water, and bicarbonate. 3 We have reported that renal tubular damage (RTD) is common and is a risk factor for deterioration of renal function in the general population, suggesting that there is an association between RTD and early abnormality in renal function. 4 Furthermore, some reports have indicated that in a population living in a cadmium-polluted region, severe RTD is related to future cardiovascular disease, as well as glomerular damage. 5, 6 Urinary β 2 -microglobulin is a low molecular weight protein, produced by all cells expressing major histocompatibility complex class I antigen. 7 It is readily filtered through the glomerulus and almost completely reabsorbed by the proximal tubules. 8 When proximal tubule cells are damaged, an increase in excretion of urinary β 2 -microglobulin results from impaired reabsorption in the proximal tubule. Therefore, urinary β 2 -microglobulin is a reliable marker of RTD. 9 Excretion of urinary β 2 -microglobulin was reported to be enhanced in patients with CHF as well as urinary albumin and protein.
(UBCR) is an independent predictor for deterioration of renal function. 4, 11 However, the impact of RTD on cardiac prognosis in patients with CHF has not yet been fully elucidated. The aim of the present study was to determine whether the comorbidity of RTD, as assessed by UBCR, predicts cardiac prognosis in patients with CHF.
Methods

Study Subjects
This was a prospective study of 315 consecutive patients who were admitted to our hospital for the diagnosis or treatment of CHF. Patients were stable for a median 713 days before their admission. The diagnosis of CHF was made by 2 cardiologists who used the generally accepted Framingham criteria, including a history of dyspnea and symptomatic exercise intolerance, with signs of pulmonary congestion or peripheral edema and radiological or echocardiographic evidence of left ventricular enlargement or dysfunction. 12 Transthoracic echocardiography was performed by physicians who were blinded to the biochemical data. The diagnoses of hypertension, diabetes mellitus, and hyperlipidemia were established on the basis of the patient's medical records or history of current or previous medical therapy. Twenty-two patients were excluded from the present study because of acute coronary syndrome within 3 months preceding admission, dialysis, active hepatic disease, pulmonary disease, or malignant disease.
Demographic and clinical data, including age, sex, and New York Heart Association (NYHA) functional class, were collected from hospital medical records and patient interviews. Medications at discharge were also collected from hospital medical records.
Biochemical Markers
Urine and venous blood samples were obtained in the early morning within 24 hours after admission. Urinary β 2 -microglobulin Data are expressed as mean±SD, number (percentage), or median (interquartile range). ACEIs indicates angiotensin-converting enzyme inhibitors; ARBs, angiotensin II receptor blockers; BNP, brain natriuretic peptide; CHF, chronic heart failure; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; Hb, hemoglobin; LVEDD, Left ventricular end-diastolic dimension; LVEF, Left ventricular ejection fraction; NAG, N-acetyl-β-D-glucosamidase; NYHA, New York Heart Association; RTD, renal tubular damage; UACR, urinary microalbumin-creatinine ratio; and UBCR, urinary β 2 -microglobulin-creatinine ratio.
concentrations were determined by the latex agglutination method (BML, Inc, Tokyo, Japan). β 2 -microglobulin levels were corrected for urinary creatinine (UBCR). Because UBCR was not normally distributed, we used log 10 UBCR for all analyses. RTD was defined as a UBCR≥300 μg/g (log 10 UBCR≥2.47 μg/g), as previously reported. 4 We quantitatively measured urinary albumin by immunoturbidimetry in a single spot urine specimen collected in the early morning. Urinary albumin levels were corrected for urinary creatinine in a single manner to urinary microalbumin-creatinine rate (UACR). N-acetyl-β-D-glucosamidase (NAG) level, a marker of early RTD, was measured in single spot urine specimens. UACR and NAG were also not normally distributed, and we used log 10 UACR and log 10 NAG for all analyses. We detected urinary protein with albumin-specific dipsticks at the same time. We defined proteinuria as positive dipstick test (≥1+). The glomerular filtration rate (GFR) was estimated using the modification of diet in the equation of the renal disease with the Japanese coefficient, as previously reported. 13 Chronic kidney disease (CKD) was defined as a reduced estimated GFR (eGFR; <60 mL/min per 1.73 m 2 ) or presence of proteinuria according to K/DOQI (Kidney Disease Outcomes Quality Initiative) clinical guideline.
14,15
End Points and Follow-up
Patients were prospectively followed up for a median period of 1097 days (range, 794-1244). Patients were followed by telephone interview or review of the medical record twice a year until 1250 days. There were 14 patients who were not followed up because of noncardiac death. The end points were cardiac death, defined as death attributable to progressive heart failure, sudden cardiac death, acute myocardial infarction, and progressive heart failure requiring rehospitalization. Sudden cardiac death was defined as death without definite premonitory symptoms or signs, and was confirmed by the attending physician. The study was approved by the Institutional Ethics Committee, and all patients gave written informed consent.
Statistical Analysis
All values are expressed as mean±SD or medians. The t test and χ 2 test or linear regression analysis was used for comparison of continuous and categorical variables, respectively. The receiveroperating characteristics curves for cardiac event were constructed to determine optimal sensitivity and specificity. The area under the receiver-operating characteristics curve (AUC) was calculated by using the trapezoidal rule. 16 The Cox proportional hazard analysis was performed to identify the independent predictors for cardiac events. Predictors that were significant by univariate analysis were entered into the multivariate analysis. Proportionality assumption in Cox model was evaluated by log-minus-log survival plot. Cardiac event-free curves were constructed according to the Kaplan-Meier method and were compared using the log-rank test. Differences among groups were analyzed by ANOVA with Scheffe post hoc test. A P value <0.05 was considered statistically significant. Statistical analyses were performed using a standard software package (JMP version 8; SAS Institute, Inc, Cary, NC).
Results
Baseline Characteristics of the Study Population
The baseline characteristics of the patients are presented in Table 1 . There were 80 patients in NYHA functional class I, 115 in NYHA class II, 82 in NYHA class III, and 38 in NYHA class IV. Hypertension, diabetes mellitus, and hyperlipidemia were identified in 194 (62%), 94 (30%), and 95 (30%) patients, respectively. The pathogenesis of heart failure was dilated cardiomyopathy in 61 (19%) patients, ischemic heart disease in 72 (23%) patients, valvular heart disease in 100 (32%) patients, and other conditions in the remaining 82 (26%) patients. The median log 10 UBCR was 2.25 μg/g. The relationships between UBCR and eGFR and UBCR and UACR was weak and moderate, respectively (eGFR: r=−0.232, P<0.0001; UACR: r=0.412, P<0.0001, respectively). RTD was identified in 120 (38%) patients. All CHF patients were divided into 2 groups according to the presence of RTD. Patients with RTD were older and were in more severe NYHA functional classes than those without RTD. The prevalence of diabetes mellitus and proteinuria was higher in patients with compared with those without RTD. Furthermore, patients with RTD had a lower eGFR and hemoglobin (Hb) level and higher brain natriuretic peptide (BNP), UACR, and NAG levels. Patients with RTD took more loop diuretics and higher dose of furosemide than those without RTD. There were no significant differences in other variables, including sex, prevalence of hypertension and hyperlipidemia, pathogenesis of CHF, and medication, excluding loop diuretics and echocardiographic parameters between patients with and without RTD.
UBCR and Clinical Outcomes
Log 10 UBCR was increased with advancing NYHA functional class (Figure 1 ). During the follow-up period, there were 91 cardiac events (29%), including 16 cardiovascular deaths and 75 rehospitalizations for worsening heart failure. The causes of cardiac death were worsening CHF in 14 patients, sudden cardiac death in 1 patient, and acute myocardial infarction in 1 patient.
To determine the risk factors for cardiac events, univariate and multivariate Cox proportional hazard regression analyses were performed (Table 2 ). Univariate analysis showed that log 10 UBCR and RTD were significantly associated with cardiac events. Furthermore, age, NYHA functional class, eGFR, BNP, Hb, UACR, proteinuria, left ventricular ejection fraction (EF), NAG, CKD, and dosages of furosemide were associated with cardiac events. Multivariate Cox proportional hazard analysis revealed that RTD was an independent predictor for cardiac events after adjustment of age, NYHA functional class, BNP, Hb, proteinuria, dosages of furosemide, and CKD (hazard ratio, 3.18; 95% confidence interval, 1.92-5.30; P<0.0001; Table 2 ). Furthermore, when NAG was substituted for RTD, NAG was also an independent predictor for cardiac events after adjustment for other confounding factors (data not shown). Kaplan-Meier analysis demonstrated that patients with RTD had a significantly higher rate of cardiac events compared with those without RTD (Figure 2A) . Furthermore, cardiac mortality was higher in patients with compared with those without RTD ( Figure 2B ).
Comorbidity of RTD and CKD in Patients With CHF
All patients with CHF were divided into 4 groups according to the presence of CKD and RTD: (1) Table 3 , levels of Hb were lower in RTD group than in normal group and CKD group. CKD+RTD group were older and had higher BNP, log 10 UBCR, and log 10 NAG than normal group and CKD group. CKD+RTD group also had lower Hb compared with normal group and CKD group. CKD+RTD group showed higher prevalence of proteinuria, higher log 10 UACR, and lower eGFR compared with other groups. The Cox proportional hazards regression analysis revealed that the CKD+RTD group had the highest risk for cardiac events among 4 groups after adjustment of age, NYHA functional class, BNP, Hb, proteinuria, and dosages of furosemide ( Figure 3A) . Because RTD is a risk factor for deterioration of CKD, new development of CKD is likely to occur in RTD group during followup periods. We divided the study patients into the following 3 groups: normal group, CKD or RTD group, and CKD+RTD group. Log-minus-log survival plot showed that hazard ratios of variables were constant overtime. Kaplan-Meier analysis BNP indicates brain natriuretic peptide; CKD, chronic kidney disease; GFR, glomerular filtration rate; Hb, hemoglobin; LVEDD, left ventricular end-diastolic dimension; LVEF, left ventricular ejection fraction; NAG, N-acetyl-β-D-glucosamidase; NYHA, New York Heart Association; RTD, renal tubular damage; UACR, urinary microalbumincreatinine ratio; and UBCR, urinary β 2 -microglobulin-creatinine ratio.
normal group (n=110): CKD (−) and RTD (−); (2) CKD group (n=85): CKD (+) and RTD (−); (3) RTD group (n=39): CKD (−) and RTD (+); (4) CKD+RTD group (n=81): CKD (+) and RTD (+). As shown in
demonstrated that CKD+RTD group had the highest rate of cardiac events in patients with CHF ( Figure 3B ). Furthermore, we performed subgroup analysis. Kaplan-Meier analysis showed that the rate of cardiac events was higher in patients with RTD than in those without it, irrespective of having CKD ( Figure 2 in the online-only Data Supplement).
Comparison of Prognostic Value Between UBCR and Traditional Markers
We performed the receiver-operating characteristics analyses to evaluate whether log 10 UBCR could add clinical information to traditional markers, such as left ventricular EF, left ventricular end-diastolic dimension, and BNP. As shown in Figure 4 , the AUC, sensitivity, and specificity of log 10 UBCR was 0.74, 68%, and 77%, respectively. The AUC of UBCR was higher than that of traditional markers of heart failure.
Discussion
The new and important findings from this study were (1) RTD was increased with advancing NYHA functional class; (2) multivariate Cox proportional hazard analysis demonstrated that RTD was an independent predictor of cardiac events; (3) Kaplan-Meier analysis demonstrated that the rate of cardiac events was higher in patients with RTD compared with those without RTD; (4) the Cox proportional hazard regression analysis revealed that comorbidity of RTD and CKD was associated with the highest risk in patients with CHF.
Association Between CHF and RTD
A cardiorenal interaction was noted in patients with CHF. [17] [18] [19] Accumulating evidence indicates that renal dysfunction has a close association with cardiac function in patients with CHF through activation of the renin-angiotensin system, volume expansion, cytokine secretion, sympathetic nerve activation, and anemia. 1, 2, 17, 19 Cardiac dysfunction with low cardiac output decreases renal perfusion and leads to renal parenchymal hypoxia. 17 Renal parenchymal hypoxia plays a pivotal role in the development of RTD. 20 We previously reported that the prevalence of RTD is ≈13% in the Japanese general population. 4 In the present study, 38% of patients with CHF were found to have RTD. The prevalence of RTD was higher in patients with CHF than in the general population, suggesting an association between cardiac function and RTD. Renal parenchymal hypoxia and, in particular, chronic tubulointerstitial hypoxia is recognized as a final common pathway for end-stage renal dysfunction, that eventually leads to a decreased GFR. 21, 22 Therefore, CHF patients with RTD may have a poor prognosis because of their renal dysfunction. However, left ventricular EF was not lower in patients with RTD compared with those without RTD. This may be attributed to the fact that chronic tubulointerstitial hypoxia is induced by several factors, including age, hypertension, diabetes mellitus, and CKD itself. 23 Because peritubular interstitial cells produce erythropoietin, 24 RTD is likely to cause renal anemia. As shown in Table 3 , decreased Hb levels were more closely associated with RTD than CKD. Anemia promoted by RTD may deteriorate cardiac prognosis in patients with CHF.
Differences Between NAG and UBCR in Patients With CHF
Both urinary NAG and UBCR are considered to be reliable markers for RTD. NAG is an enzyme, which localizes in the lysosomes of proximal tubular cells. Urinary NAG levels often increase through the exocytosis-endocytosis pathway, which is a different pathway from that of RTD. 25, 26 A previous report suggested that UBCR is superior to NAG for predicting renal dysfunction. 27 UBCR was considered as a more specific marker than NAG. Damman et al 28 showed that a high NAG level was a risk factor for future cardiac events in patients with CHF. Similarly, NAG was also an independent predictor for cardiac events in the present study. These findings supported our hypothesis that the comorbidity of RTD is associated with a poor prognosis in patients with CHF.
The limitation of this study was relatively high EF in the study population. The relatively high EF (51±17%) observed in this study may primarily be the result of a lower prevalence of ischemic heart diseases in Japan (23%). The prevalence of ischemic heart disease is reportedly relatively lower in Japan compared with the United States and European countries. 29, 30 The mean EF in this study is thought to be equivalent to that seen in Japanese heart failure study and the Japanese heart failure registry. 31, 32 Another limitation of the present study was the relatively small number of study subjects.
In conclusion, RTD, as assessed by UBCR, was related to the severity of heart failure and was associated with a high risk of cardiac events in patients with CHF. The comorbidity of RTD could add clinical information to CKD and may be a crucial risk factor for cardiac events in patients with CHF.
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